TiumBio Balance Sheet Health
Financial Health criteria checks 3/6
TiumBio has a total shareholder equity of ₩61.7B and total debt of ₩26.1B, which brings its debt-to-equity ratio to 42.4%. Its total assets and total liabilities are ₩99.7B and ₩38.0B respectively.
Key information
42.4%
Debt to equity ratio
₩26.15b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩22.63b |
| Equity | ₩61.68b |
| Total liabilities | ₩37.98b |
| Total assets | ₩99.66b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A321550's short term assets (₩28.2B) exceed its short term liabilities (₩11.0B).
Long Term Liabilities: A321550's short term assets (₩28.2B) exceed its long term liabilities (₩27.0B).
Debt to Equity History and Analysis
Debt Level: A321550's net debt to equity ratio (5.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A321550's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A321550 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A321550 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.8% each year